Malta
Tuberculosis profile
Population  2013 <1 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) <0.01 (<0.01–<0.01) 0.36 (0.35–0.36)
Mortality (HIV+TB only) 0 (–) 0 (–)
Prevalence  (includes HIV+TB) 0.06 (0.024–0.11) 14 (5.6–26)
Incidence  (includes HIV+TB) 0.049 (0.046–0.054) 11 (11–13)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.42 (0.4–0.42)
Case detection, all forms (%) 100 (93–110)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 0 (0–25) 0 (0–98)
MDR-TB cases among notified pulmonary
TB cases
0 (0–9) 0 (0–0)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 23   0
Pulmonary, clinically diagnosed 15   0
Extrapulmonary 12   0
       
Total new and relapse 50    
Previously treated, excluding relapses 0    
Total cases notified 50    
Among 50 new and relapse cases:
0 (0%) cases aged under 15 years; male:female ratio: 2.3
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 20 (87%) 0 27
Laboratory-confirmed RR-/MDR-TB cases     2
Patients started on MDR-TB treatment     0
TB/HIV 2013 Number (%)
TB patients with known HIV status 38 (76)
HIV-positive TB patients 0 (0)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 24
Previously treated cases, excluding relapse, registered in 2012  
HIV-positive TB cases, all types, registered in 2012 50
RR-/MDR-TB cases started on second-line treatment in 2011  
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, outside
country
Financing TB control 2014  
National TB programme budget (US$ millions) <1
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-07-01 Data: www.who.int/tb/data